GALNT9 and small cell lung carcinoma: Here, we find that the glycosyltransferase GALNT9 is highly expressed in NEPC, small cell lung cancer (SCLC), and neuroendocrine colon cancers, leading to an increased presence of O‐GalNAc glycosylation on the cell surface.